Brief: Egenesis And Eledon Pharmaceuticals Announce Collaboration For Use Of Tegoprubart In Preclinical Xenotransplantation Studies
09/01/2023 13:57
Eledon Pharmaceuticals Inc ELDN.O :
* EGENESIS AND ELEDON PHARMACEUTICALS ANNOUNCE COLLABORATION
FOR
USE OF TEGOPRUBART IN PRECLINICAL XENOTRANSPLANTATION STUDIES
Source text for Eikon: ID:nGNX5bKdsY
Further company coverage: ELDN.O
Recent news on Eledon Pharmaceuticals
See all newsBrief: Eledon Presents Updated Long-Term Phase 2 Bestow Extension Study Results At The International Congress Of The Transplantation Society
Eledon Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Eledon Pharmaceuticals Q2 net loss widens on warrant liability changes
Eledon Pharmaceuticals Inc expected to post a loss of 16 cents a share - Earnings Preview
Brief: Natera And Eledon Announce Strategic Partnership For Prospera™ Monitoring In Planned Phase 3 Kidney Transplant Trial